Skylight Health Group Announces Expected Date of NASDAQ Exchange Listing
Skylight Health Group Inc. announced the upcoming trading of its common shares on the Nasdaq Capital Market under the symbol SLHG, starting the week of June 7, 2021. This follows their share consolidation effective May 28, 2021. The company will maintain its listing on TSX Venture Exchange as SHG and continue trading on OTCQX as SHGFF. Skylight Health operates a multi-state primary care network, focusing on transitioning from fee-for-service to value-based care, enhancing patient outcomes and financial performance.
- Upcoming Nasdaq listing will enhance visibility and credibility.
- Focus on value-based care may improve patient outcomes and financial performance.
- Dependency on meeting Nasdaq's bid price requirement.
- Risks associated with the execution of the business strategy and revenue growth.
TORONTO, May 27, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (TSXV:SHG; OTCQX: SHGFF) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, is pleased to announce that further to its press release dated May 13, 2021, it has received confirmation from The Nasdaq Stock Market LLC (“Nasdaq”) that its common shares will be able to commence trading on the Nasdaq Capital Market during the week of June 7, 2021 under the symbol “SLHG”, subject to the Company meeting the applicable bid price requirement for listing during the period beginning on the date of the Company’s share consolidation on May 28, 2021 through the initial listing date.
Skylight Health will retain its listing on The TSX Venture Exchange under the symbol “SHG”. The Company will continue to trade to trade on the OTCQX under the symbol “SGHFF” until trading on the Nasdaq commences.
ABOUT SKYLIGHT HEALTH GROUP INC.
Skylight Health Group (TSXV:SHG; OTCQX:SHGFF) is a healthcare services and technology company, working to positively impact patient health outcomes. The Company operates a US multi-state primary care health network comprised of physical practices providing a range of services from primary care, sub-specialty, allied health, and laboratory/diagnostic testing. The Company is focused on helping small and independent practices shift from a traditional fee-for-service (FFS) model to value-based care (VBC) through tools including proprietary technology, data analytics and infrastructure. In a FFS model, payors (commercial and government insurers) reimburse on an encounter-based approach. This puts a focus on volume of patients per day. In a VBC model, payors reimburse typically on a capitation (fixed fee per member per month) basis. This places an emphasis on quality over volume. VBC will lead to improved patient outcomes, reduced cost of delivery and drive stronger financial performance from existing practices.
For more information, please visit www.skylighthealthgroup.com or contact:
Investor Relations:
Jackie Kelly
investors@skylighthealthgroup.com
416-301-2949
Currency Usage, Cautionary and Forward-Looking Statements
All currency contained in this Press Release represent Canadian Dollars unless otherwise stated.
Cautionary Statement Regarding Forward Looking Information
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Skylight Health's filings with Canadian and United States securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should," and similar expressions, are forward-looking statements.
Forward-looking statements may include, without limitation, statements regarding the listing of our common shares on Nasdaq.
Although Skylight Health has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: the ability of Skylight Health to execute on its business strategy, continued revenue growth in accordance with management's expectations, operating expenses continuing in accordance with management expectations, dependence on obtaining regulatory approvals; Skylight Health being able to find, complete and effectively integrate target acquisitions; change in laws relating to health care regulation; reliance on management; requirements for additional financing; competition; hindering market growth or other factors that may not currently be known by the Company.
There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.
Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. Skylight Health disclaims any intention or obligation to update or revise such information, except as required by applicable law, and Skylight Health does not assume any liability for disclosure relating to any other company mentioned herein.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
FAQ
When will Skylight Health Group start trading on Nasdaq under the symbol SLHG?
What is the stock symbol for Skylight Health Group on Nasdaq?
Will Skylight Health continue trading on TSX and OTCQX?
What is Skylight Health's focus regarding healthcare services?
What are the risks related to Skylight Health's business strategy?
